Next Research announces the delivery of the 1st wave of the Pricing insight Monitor for the top 5 markets in Europe.

17 01 2014

The Pricing Insight Monitor (PIM) has now been delivered to the initial syndicate of clients and is also available to purchase for immediate delivery by other clients requiring essential competitive awareness for discount prices on pharmaceutical products.

The therapeutic areas that the PIM is reporting on are:

  • Biologicals – RA specific Markets
  • Asthma & COPD
  • Type 2 Diabetes
  • Immunosuppressant’s
  • Multiple Sclerosis (MS)
  • Ophthalmology (selected products)

The sample for the Pricing Insight Monitor represents the individual brand/ product discount information for over 1,000 hospitals in the major 5 EU Markets.

The data is now available for immediate delivery and can be purchased either by individual market area and/or by individual country.   

Please contact Next Research for further information and don’t miss out on this essential business critical data. 

Please contact Russell Mills:

Russellmills@nextresearch.co.uk

+44 (0)7973658388

or Info@nextresearch.co.uk

 

 





Launch of the Pricing Insight Monitor for Biological products

23 01 2013

The Pricing Insight Monitor (PIM), from Next Research. The PIM covers a pharma companies own and competitor pricing discount information from a significant sample of European Hospitals and they Buyers for these hospitals.

This syndicated version of the Pricing Insight Monitor (PIM) is therapy focused on 6 markets including Biolgical and Biosimilars products and provide the following information :-

Discounting levels and packages offered by own and competitors (discount % for average, highest and lowest discounts)

The competitive packages offered by each brand/ biosimilar product and how they are received by the key purchasers.

Influencing factors could affect the level of discount offered (e.g. volume purchased, exclusivity of use, support/ training etc).

The PIM will cover the tope 5 European Hospital Markets and extensive robust sample in each market (up to 50 hospitals providing discount information in each country, split by type and size and other variables etc).

The PIM is launching in Early/ Mid 2013, please contact Next Research for further information.

Please contact Russell Mills:

Russellmills@nextresearch.co.uk

+44 (0)7973658388

or Info@nextresearch.co.uk

WWW.NextResearch.Co.UK